P & P MEDICAL LTDActive

Company number SC444364Private limited companyIncorporated 2013
⚠ Confirmation statement overdue. It was due on 18 Oct 2026.

Key figures

£15,089+247.8%
Net assets 2025/26
+4.1%
Average annual growth 2020/21–2025/26
-5 k05 k10 k15 k20 k2020/212021/222022/232023/242024/252025/26

Like most small UK companies, P & P MEDICAL LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 k100 k150 k2020/212021/222022/232023/242024/252025/26
Filed accounts2020/21–2025/26
2021/222022/232023/242024/252025/26
Cash at bank and in hand31,21318,05522,63558,87438,050
Total assets36,21353,56785,12170,81148,055
Total liabilities97,65983,30282,39566,47236,598
Net assets / total equity-48187804,33915,089
Average number of employees0-1-113

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: P & P MEDICAL LTD

Company

P & P MEDICAL LTD is a private limited company registered with Companies House under company number SC444364. It was incorporated on 6 Mar 2013. Its status is active. The registered office is in Glasgow (G3). Its nature of business (SIC 2007) is general medical practice activities (86210).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Mar 2026); the company files small company accounts (filleted). Net assets were £15,089, up 247.8% on the previous year. Cash at bank and in hand was £38,050. Total assets were £48,055 and total liabilities £36,598. The company had an average of 3 employees. Figures are available for 6 financial years (2020/21–2025/26).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Dec 2027. The next confirmation statement is due by 18 Oct 2026.